Notable Upgrades: BioMarin Pharmaceutical (BMRN), Facebook (FB), ChinaCache (CCIH), Novavax (NVAX), Amazon.com (AMZN)

Analysts at Deutsche Bank (DB) are out with a report this morning reiterating shares of BioMarin Pharmaceutical Inc. (BMRN) with a ‘Buy‘. The firm raised also its price target for the company to $140 from $90, implying 55% upside. BioMarin Pharmaceutical Inc. shares have a t-12 price-to-sales ratio of 24.48. EPS for the same period […] View the full post at: Notable Upgrades: BioMarin Pharmaceutical (BMRN), Facebook (FB), ChinaCache (CCIH), Novavax (NVAX), Amazon.com (AMZN) Related posts: Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock Caterpillar Inc. Downgraded to “Neutral” at BofA